Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
1981 1
1985 3
1986 1
1988 3
1990 6
1991 5
1992 6
1993 6
1994 10
1995 7
1996 5
1997 12
1998 8
1999 8
2000 4
2001 10
2002 11
2003 17
2004 16
2005 8
2006 15
2007 12
2008 14
2009 12
2010 18
2011 23
2012 28
2013 33
2014 25
2015 22
2016 15
2017 23
2018 15
2019 22
2020 33
2021 33
2022 29
2023 29
2024 13

Text availability

Article attribute

Article type

Publication date

Search Results

501 results

Results by year

Filters applied: . Clear all
Page 1
Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment.
Duma N, Santana-Davila R, Molina JR. Duma N, et al. Mayo Clin Proc. 2019 Aug;94(8):1623-1640. doi: 10.1016/j.mayocp.2019.01.013. Mayo Clin Proc. 2019. PMID: 31378236 Review.
In the past decade, significant advances have been made in the science of non-small cell lung cancer (NSCLC). Screening has been introduced with the goal of early detection. ...However, important drawbacks exist that limit its discriminatory potential. …
In the past decade, significant advances have been made in the science of non-small cell lung cancer (NSCLC). Screening …
Lung cancer: diagnosis and management.
Collins LG, Haines C, Perkel R, Enck RE. Collins LG, et al. Am Fam Physician. 2007 Jan 1;75(1):56-63. Am Fam Physician. 2007. PMID: 17225705 Free article. Review.
Smoking remains the predominant risk factor for lung cancer. Lung cancers are categorized as small cell carcinoma or non-small cell carcinoma (e.g., adenocarcinoma, squamous cell carcinoma, large cell …
Smoking remains the predominant risk factor for lung cancer. Lung cancers are categorized as small cell carci …
Emerging Strategies for the Treatment of Small Cell Lung Cancer: A Review.
Petty WJ, Paz-Ares L. Petty WJ, et al. JAMA Oncol. 2023 Mar 1;9(3):419-429. doi: 10.1001/jamaoncol.2022.5631. JAMA Oncol. 2023. PMID: 36520421 Review.
IMPORTANCE: Small cell lung cancer (SCLC) is an aggressive disease that is characterized by rapid growth and the early development of metastases. ...Recently, immunotherapy-based regimens have become available for the management of SCLC, with 2 programmed …
IMPORTANCE: Small cell lung cancer (SCLC) is an aggressive disease that is characterized by rapid growth and the early …
Small-cell lung cancer brain metastasis: From molecular mechanisms to diagnosis and treatment.
Zhu Y, Cui Y, Zheng X, Zhao Y, Sun G. Zhu Y, et al. Biochim Biophys Acta Mol Basis Dis. 2022 Dec 1;1868(12):166557. doi: 10.1016/j.bbadis.2022.166557. Epub 2022 Sep 24. Biochim Biophys Acta Mol Basis Dis. 2022. PMID: 36162624 Free article. Review.
Lung cancer is the most malignant human cancer worldwide, also with the highest incidence rate. However, small-cell lung cancer (SCLC) accounts for 14 % of all lung cancer cases. ...
Lung cancer is the most malignant human cancer worldwide, also with the highest incidence rate. However, small-cell …
Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer.
Rolfo C, Mack P, Scagliotti GV, Aggarwal C, Arcila ME, Barlesi F, Bivona T, Diehn M, Dive C, Dziadziuszko R, Leighl N, Malapelle U, Mok T, Peled N, Raez LE, Sequist L, Sholl L, Swanton C, Abbosh C, Tan D, Wakelee H, Wistuba I, Bunn R, Freeman-Daily J, Wynes M, Belani C, Mitsudomi T, Gandara D. Rolfo C, et al. J Thorac Oncol. 2021 Oct;16(10):1647-1662. doi: 10.1016/j.jtho.2021.06.017. Epub 2021 Jul 8. J Thorac Oncol. 2021. PMID: 34246791 Free article. Review.
Although precision medicine has had a mixed impact on the clinical management of patients with advanced-stage cancer overall, for NSCLC, and more specifically for lung adenocarcinoma, the advances have been dramatic, largely owing to the genomic complexity and growi …
Although precision medicine has had a mixed impact on the clinical management of patients with advanced-stage cancer overall, for NSC …
Current Diagnosis and Management of Small-Cell Lung Cancer.
Wang S, Zimmermann S, Parikh K, Mansfield AS, Adjei AA. Wang S, et al. Mayo Clin Proc. 2019 Aug;94(8):1599-1622. doi: 10.1016/j.mayocp.2019.01.034. Mayo Clin Proc. 2019. PMID: 31378235 Review.
Small-cell lung cancer (SCLC) is an aggressive disease with distinct pathological, clinical, and molecular characteristics from non-small-cell lung cancer. SCLC has high metastatic potential, resulting in a clinically poor prognosis. Earl …
Small-cell lung cancer (SCLC) is an aggressive disease with distinct pathological, clinical, and molecular characterist …
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Ganti AKP, Loo BW, Bassetti M, Blakely C, Chiang A, D'Amico TA, D'Avella C, Dowlati A, Downey RJ, Edelman M, Florsheim C, Gold KA, Goldman JW, Grecula JC, Hann C, Iams W, Iyengar P, Kelly K, Khalil M, Koczywas M, Merritt RE, Mohindra N, Molina J, Moran C, Pokharel S, Puri S, Qin A, Rusthoven C, Sands J, Santana-Davila R, Shafique M, Waqar SN, Gregory KM, Hughes M. Ganti AKP, et al. J Natl Compr Canc Netw. 2021 Dec;19(12):1441-1464. doi: 10.6004/jnccn.2021.0058. J Natl Compr Canc Netw. 2021. PMID: 34902832 Free PMC article.
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Small Cell Lung Cancer (SCLC) provide recommended management for patients with SCLC, including diagnosis, primary treatment, surveillance for relapse, and subsequent treatment. This selec …
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Small Cell Lung Cancer (SCLC) provide recommend …
Radiation Therapy for Small Cell Lung Cancer: An ASTRO Clinical Practice Guideline.
Simone CB 2nd, Bogart JA, Cabrera AR, Daly ME, DeNunzio NJ, Detterbeck F, Faivre-Finn C, Gatschet N, Gore E, Jabbour SK, Kruser TJ, Schneider BJ, Slotman B, Turrisi A, Wu AJ, Zeng J, Rosenzweig KE. Simone CB 2nd, et al. Pract Radiat Oncol. 2020 May-Jun;10(3):158-173. doi: 10.1016/j.prro.2020.02.009. Epub 2020 Mar 23. Pract Radiat Oncol. 2020. PMID: 32222430 Free PMC article.
PURPOSE: Several sentinel phase III randomized trials have recently been published challenging traditional radiation therapy (RT) practices for small cell lung cancer (SCLC). This American Society for Radiation Oncology guideline reviews the evidence f …
PURPOSE: Several sentinel phase III randomized trials have recently been published challenging traditional radiation therapy (RT) pra …
Activation of PI3K/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung Cancer.
Jin Y, Chen Y, Tang H, Hu X, Hubert SM, Li Q, Su D, Xu H, Fan Y, Yu X, Chen Q, Liu J, Hong W, Xu Y, Deng H, Zhu D, Li P, Gong Y, Xia X, Gay CM, Zhang J, Chen M. Jin Y, et al. Clin Cancer Res. 2022 Feb 1;28(3):526-539. doi: 10.1158/1078-0432.CCR-21-1943. Epub 2021 Dec 17. Clin Cancer Res. 2022. PMID: 34921019
PURPOSE: Here, we have investigated treatment resistance mechanisms in small cell lung cancer (SCLC) by focusing on comparing the genotype and phenotype in tumor samples of treatment-resistant and treatment-sensitive SCLC. EXPERIMENTAL DESIGN: We conducted wh …
PURPOSE: Here, we have investigated treatment resistance mechanisms in small cell lung cancer (SCLC) by focusing on com …
Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Silvestri GA, Gonzalez AV, Jantz MA, Margolis ML, Gould MK, Tanoue LT, Harris LJ, Detterbeck FC. Silvestri GA, et al. Chest. 2013 May;143(5 Suppl):e211S-e250S. doi: 10.1378/chest.12-2355. Chest. 2013. PMID: 23649440
BACKGROUND: Correctly staging lung cancer is important because the treatment options and prognosis differ significantly by stage. ...Understanding the accuracy, advantages, and disadvantages of the available methods for staging non-small cell …
BACKGROUND: Correctly staging lung cancer is important because the treatment options and prognosis differ significantly by …
501 results